Allergic bronchopulmonary aspergillosis
MONDO:0015243Allergic bronchopulmonary aspergillosis (ABPA) is a rare immunologic pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus, clinically manifesting with poorly controlled asthma and recurrent pulmonary infiltrates.
Also known as: ABPA, Hinson-Pepys disease, allergic aspergillosis, allergic bronchopulmonary aspergillosis, familial, allergic bronchopulmonary mycosis, aspergillosis, allergic bronchopulmonary
24 clinical trials for this condition and its sub-types, 15 tagged with Allergic bronchopulmonary aspergillosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic bronchopulmonary aspergillosis
-
Malt worker's lung 0 trials
-
Can an injected biologic cut steroid Flare-Ups in a Tough-to-Treat asthma complication?
Disease control Not yet recruitingResearchers are studying depemokimab, an injected biologic drug, in adults aged 18 to 75 who have allergic bronchopulmonary aspergillosis (ABPA) along with severe eosinophilic asthma. The study tracks how many asthma attacks need systemic steroids and whether participants' qualit…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Can a single injection tame severe asthma in fungal allergy?
Disease control Not yet recruitingThis study is testing whether tezepelumab, an injectable medication, can help people with severe asthma caused by allergic bronchopulmonary aspergillosis (ABPA), a condition where the immune system overreacts to certain fungi. The trial will enroll 10 adults aged 18 to 75 who hav…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC